SG Americas Securities
ZYME icon

SG Americas Securities’s Zymeworks ZYME Stock Holding History

SG Americas Securities’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
10,429
-7,128
-41% -$169K ﹤0.01% 2520
2025
Q4 		$462K Buy
17,557
+3,933
+29% +$85.8K ﹤0.01% 2543
2025
Q3 		$233K Buy
13,624
+4,953
+57% +$70.9K ﹤0.01% 2659
2025
Q2 		$109K Sell
8,671
-89,494
-91% -$1.07M ﹤0.01% 2601
2025
Q1 		$1.17M Buy
98,165
+71,383
+267% +$973K ﹤0.01% 1062
2024
Q4 		$392K Buy
26,782
+6,239
+30% +$87.2K ﹤0.01% 1561
2024
Q3 		$258K Buy
20,543
+9,950
+94% +$108K ﹤0.01% 2278
2024
Q2 		$90K Sell
10,593
-6,840
-39% -$60.9K ﹤0.01% 2574
2024
Q1 		$183K Sell
17,433
-10,006
-36% -$111K ﹤0.01% 2044
2023
Q4 		$285K Buy
27,439
+2,481
+10% +$19.8K ﹤0.01% 1865
2023
Q3 		$158K Buy
+24,958
New +$184K ﹤0.01% 2463
2022
Q1 		– Sell
-269,151
Closed -$4.41M – 3522
2021
Q4 		$4.41M Buy
269,151
+49,049
+22% +$1.02M 0.02% 559
2021
Q3 		$6.39M Sell
220,102
-2,619
-1% -$87.1K 0.03% 432
2021
Q2 		$7.73M Buy
222,721
+31,230
+16% +$991K 0.04% 437
2021
Q1 		$6.05M Buy
191,491
+173,594
+970% +$7.05M 0.03% 444
2020
Q4 		$846K Sell
17,897
-14,044
-44% -$652K ﹤0.01% 1630
2020
Q3 		$1.49M Buy
31,941
+9,379
+42% +$322K 0.01% 944
2020
Q2 		$814K Buy
22,562
+15,354
+213% +$565K 0.01% 1618
2020
Q1 		$256K Hold
7,208
– – ﹤0.01% 2339
2019
Q4 		$328K Sell
7,208
-2,013
-22% -$73.1K ﹤0.01% 2129
2019
Q3 		$229K Sell
9,221
-438
-5% -$11K ﹤0.01% 2287
2019
Q2 		$212K Sell
9,659
-1,490
-13% -$27.4K ﹤0.01% 2385
2019
Q1 		$180K Sell
11,149
-4,151
-27% -$64.4K ﹤0.01% 2642
2018
Q4 		$225K Buy
+15,300
New +$201K ﹤0.01% 2329

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SG Americas Securities's ZYME Position: Q1 2026 in Review

SG Americas Securities reduced its Zymeworks (ZYME) stake by 41% in Q1 2026, selling an estimated $169K and leaving 10,429 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

SG Americas Securities first reported a position in ZYME in Q4 2018 and has held it in 24 quarters since. The position peaked at $7.73M in Q2 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • SG Americas Securities held 10,429 shares of Zymeworks worth $261K as of Q1 2026.
  • SG Americas Securities sold 7,128 Zymeworks shares in Q1 2026, an estimated $169K.
  • Zymeworks made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2520 holding.
  • SG Americas Securities first reported a position in Zymeworks in Q4 2018 and has held it in 24 quarters since.
  • SG Americas Securities's Zymeworks position peaked at $7.73M in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.